Descrição
How we approach thrombosis risk in children with COVID-19 infection - Authorea
IJMS, Free Full-Text
Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
Clinical phenotypes and outcomes in children with multisystem inflammatory syndrome across SARS-CoV-2 variant eras: a multinational study from the 4CE consortium - eClinicalMedicine
Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China
Pulmonary Embolism and Deep Vein Thrombosis in COVID-19: A Systematic Review and Meta-Analysis
MIS-C Associated with COVID-19 Anti-thrombosis Guideline of Care for Children - Advanced Cardiac Therapies Improving Outcomes Network
Treatment of MIS-C in Children and Adolescents
Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
Biomarker Changes in Pediatric Patients With COVID-19: A Retrospective Study from a Single Center Database
Severe COVID-19 versus multisystem inflammatory syndrome: comparing two critical outcomes of SARS-CoV-2 infection
Frontiers Thromboembolic complications in children with COVID-19 and MIS-C: A narrative review
Treatment and care received by children hospitalized with COVID-19 in a large hospital network in the United States, February 2020 to September 2021
Frontiers The Spectrum of Manifestations of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV2) Infection in Children: What We Can Learn From Multisystem Inflammatory Syndrome in Children (MIS-C)
Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry - Canadian Journal of Cardiology
de
por adulto (o preço varia de acordo com o tamanho do grupo)
